Q&A: MD Anderson's Dean Tang Talks miR-34a and Its Role in Prostate Cancer
January 20, 2011
Q&A: MD Anderson's Dean Tang Talks miR-34a and Its Role in Prostate Cancer
Tang and colleagues from Mirna Therapeutics reported that the microRNA miR-34a inhibits prostate cancer stem cells, as well as metastasis, in tumor-bearing animal models of the disease.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- People in the News: Sinil Kim
June 6, 2013 / Gene Silencing News - Mirna Becomes First to Advance Therapeutic microRNA Mimic into Human Testing
May 2, 2013 / Gene Silencing News - OGT Inks Deal with Institute of Cancer Research to Advance microRNA-Based Prostate Cancer Test
March 21, 2013 / Gene Silencing News - People in the News: Clay Siegall
January 31, 2013 / Gene Silencing News - Mirna Reports Preclinical Data on Lead miRNA Replacement Drug, Focusing on Upcoming Phase I
January 24, 2013 / Gene Silencing News